GlassScriptPhysician profile
Shanna B Holcomb
NPI 1598897746
$1,764.07
in general payments reported to CMS, 2019-2025
18 companies · $92.22 in 2025
The $92.22 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.90 · 2020: $84.93 · 2021: $185 · 2022: $604 · 2023: $603 · 2024: $167 · 2025: $92.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.61 |
| Education | $185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $430.65 | 2022-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $341.04 | 2021-2025 | |
| Abbvie INC. | $235.64 | 2020-2023 | |
| Amgen INC. | $133.55 | 2019-2024 | Evenity, Prolia |
| Pfizer INC. | $112.92 | 2022-2024 | |
| Millicent US INC | $100.91 | 2024-2025 | Intrarosa, Femring |
| Myovant Sciences INC. | $82.60 | 2022 | |
| Novo Nordisk INC | $69.58 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $46.77 | 2023 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $33.54 | 2021-2022 | |
| Therapeuticsmd, INC. | $31.10 | 2020 | |
| Mylan Pharmaceuticals INC. | $27.35 | 2020-2021 | |
| Roche Diagnostics Corporation | $23.41 | 2021 | |
| Hologic Sales and Service, LLC | $21.07 | 2023 | Aptima |
| Axonics, INC. | $20.97 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $20.33 | 2022 | |
| Scynexis, INC. | $17.06 | 2022 | |
| Cosette Pharmaceuticals INC. | $15.58 | 2025 | Vyleesi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanna Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.